{"protocolSection":{"identificationModule":{"nctId":"NCT05964400","orgStudyIdInfo":{"id":"duoABLE"},"secondaryIdInfos":[{"id":"AOTFIRG23KRINGLE","type":"OTHER_GRANT","domain":"American Occupational Therapy Foundation"}],"organization":{"fullName":"University of Minnesota","class":"OTHER"},"briefTitle":"duoABLE for People With Stroke and Their Caregivers","officialTitle":"duoABLE for People With Stroke and Their Caregivers (Feasibility)"},"statusModule":{"statusVerifiedDate":"2023-10","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2023-09-01","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2024-05-01","type":"ESTIMATED"},"completionDateStruct":{"date":"2024-05-01","type":"ESTIMATED"},"studyFirstSubmitDate":"2023-07-18","studyFirstSubmitQcDate":"2023-07-18","studyFirstPostDateStruct":{"date":"2023-07-27","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-10-06","lastUpdatePostDateStruct":{"date":"2023-10-10","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"University of Minnesota","class":"OTHER"},"collaborators":[{"name":"American Occupational Therapy Foundation","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The goal of this intervention study is to test whether a behavioral program that involves people with stroke and their caregivers is acceptable, safe, and can promote physically active lifestyles using enjoyable activities. Participant duos (person with stroke and their caregiver) will be asked to complete assessments at 2 timepoints, wear an activity tracker, participate in 12 sessions with an occupational therapist, and complete an interview."},"conditionsModule":{"conditions":["Stroke","Stroke Ischemic","Stroke Hemorrhagic","Stroke Sequelae"],"keywords":["lifestyle","physical activity","duoABLE","ABLE","rehabilitation","rehab","occupational therapy","physical therapy","stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":40,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"duoABLE","type":"EXPERIMENTAL","description":"Stroke participant-caregiver duos (dyads) will meet with an occupational therapist 12 times (2x/week for 6 weeks, approximately 30 minutes/session) to apply activity monitoring, activity scheduling, collaborative problem solving, self-assessment, and social interdependence to self-selected activities that aim to increase both dyad members' physical activity levels","interventionNames":["Behavioral: duoABLE"]}],"interventions":[{"type":"BEHAVIORAL","name":"duoABLE","description":"Stroke participant-caregiver duos (dyads) will meet with an occupational therapist 12 times (2x/week for 6 weeks, approximately 30 minutes/session) to apply activity monitoring, activity scheduling, collaborative problem solving, self-assessment, and social interdependence to self-selected activities that aim to increase both dyad members' physical activity levels","armGroupLabels":["duoABLE"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Participant satisfaction","description":"Measured using the Client Satisfaction Questionnaire-8 (CSQ-8)","timeFrame":"Score at week 8"}],"secondaryOutcomes":[{"measure":"Change in activity restrictions","description":"Proportion of activities retained assessed at baseline and 8-weeks by the Activity Card Sort 3","timeFrame":"Baseline to 8 weeks"},{"measure":"Change in sedentary minutes per day","description":"Minutes of sedentary time per day, measured using the activPAL micro4 (mean minutes per day determined by 7-day wear protocol) at baseline and week 8.","timeFrame":"Baseline to 8 weeks"},{"measure":"Change in daily step count","description":"Count of steps per day, measured using the activPAL micro4 (mean daily step count determined by 7-day wear protocol) at baseline and week 8.","timeFrame":"Baseline to 8 weeks"},{"measure":"Change in Health-related quality of life","description":"Change in score on the EuroQoL-5 Dimensions-5 Levels (EQ-5D-5L) measured at baseline and week 8","timeFrame":"Baseline to 8 weeks"},{"measure":"Adverse event count","description":"Total count of adverse events over the course of the study based on an adverse events questionnaire completed at 8 weeks","timeFrame":"Count of adverse events at week 8"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria (Stroke Participants):\n\n* Stroke diagnosed more than 6 months ago\n* Are 18 years of age or older\n* Report ≥6 hours of sedentary behavior on a typical day OR report engagement in ≤90 minutes of moderate-to-vigorous physical activity in the past week\n* Reside in a community-based setting\n* Are mobile within their home, with or without an assistive device and without physical assistance\n* Are able to identify an eligible caregiver who will engage in assessments and intervention.\n\nInclusion Criteria (Caregiver Participants):\n\n* Are 18 years of age or older\n* Report ≥6 hours of sedentary behavior on a typical day OR report engagement in ≤90 minutes of moderate-to-vigorous physical activity in the past week\n* Reside in a community-based setting\n* Are mobile within their home, with or without an assistive device and without physical assistance\n\nExclusion Criteria (Stroke Participants):\n\n* Severe aphasia\n* Are currently receiving chemotherapy or radiation treatments for cancer\n* Have a medical diagnosis of neurodegenerative disorder (i.e., dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, glioblastoma)\n* Received inpatient treatment for substance use disorder or psychiatric condition within the past 12 months\n* Have a history of skin sensitivity related to adhesives\n* Are pregnant or expecting to become pregnant in the next 2 months\n* Reside in an institutional setting\n* Are currently incarcerated\n\nExclusion Criteria (Caregiver Participants):\n\n* Have a history of skin sensitivity related to adhesives\n* Are currently receiving chemotherapy or radiation treatments for cancer\n* Have a medical diagnosis of neurodegenerative disorder (i.e., dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, glioblastoma)\n* Received inpatient treatment for substance use disorder or psychiatric condition within the past 12 months\n* Are pregnant or expecting to become pregnant in the next 2 months\n* Reside in an institutional setting\n* Are currently incarcerated","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Karli Jahnke, MOT, OTR/L","role":"CONTACT","phone":"(612) 626-4046","email":"dwell@umn.edu"}],"overallOfficials":[{"name":"Emily A Kringle, PhD, OTR/L","affiliation":"University of Minnesota","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"School of Kinesiology, University of Minnesota","status":"RECRUITING","city":"Minneapolis","state":"Minnesota","zip":"55455","country":"United States","contacts":[{"name":"Karli Jahnke, MOT, OTR/L","role":"CONTACT","phone":"612-626-4046","email":"dwell@umn.edu"}],"geoPoint":{"lat":44.97997,"lon":-93.26384}}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"There are no current plans to share data with other investigators. Upon the completion of the study, a de-identified dataset that includes questionnaire data, raw and processed activPAL data, and transcribed interview data will be created and stored in the DWELL Laboratory at the University of Minnesota. The PI will consider individual requests for data sharing and provide only the necessary de-identified data upon reasonable request, under a University of Minnesota data use agreement.","infoTypes":["STUDY_PROTOCOL","SAP","ICF"]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083302","term":"Hemorrhagic Stroke"},{"id":"D000083242","term":"Ischemic Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Stroke Ischemic","relevance":"HIGH"},{"id":"M2405","name":"Hemorrhagic Stroke","asFound":"Stroke Hemorrhagic","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}